[1]
WHO Meeting on the Role of the Hospital in International Drug
Monitoring International drug monitoring: The role of the hospital,
report of a WHO meeting. Geneva . 18-23 November, 1969.
[2]
Edwards IR, Aronson JK. Adverse drug reactions: Definitions, diagnosis, and management. The Lancet 2000; 356(9237): 1255-9.
[3]
Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ 1998; 316(7140): 1295-8.
[4]
Bordet R, Gautier S, Le Louet H, Dupuis B, Caron J. Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol 2001; 56(12): 935-41.
[5]
Howard R, Avery A, Howard P, Partridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: Observational study. Qual Saf Health Care 2003; 12(4): 280-5.
[6]
Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions
as cause of admission to hospital: Prospective analysis of 18820 patients 2004; 329(7456): 15-9.
[7]
Pouyanne P, Haramburu F, Imbs JL, Bégaud B. Admissions to hospital caused by adverse drug reactions: Cross sectional incidence study. BMJ 2000; 320(7241): 1036.
[8]
Pfaffenbach G, Carvalho O, Bergsten-Mendes G. Drug adverse reactions leading to hospital admission. Rev Assoc Med Bras 2002; 48(3): 237-41.
[9]
Sabry N, Farid S, Dawoud D. Drug-related problems in cardiac children. Minerva Pediatr 2016; 68(2): 89-95.
[10]
Al-Olah Y. Al Thiab KJAoSm.. Admissions through the emergency
department due to drug-related problems. 2008; 28(6): 426.
[11]
Khan LM, Al-Harthi SE, Saadah OI. Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR. Saudi Pharm J 2013; 21(3): 261-6.
[13]
Alshammari TM, Alshakka M, Aljadhey H. Pharmacovigilance system in Saudi Arabia. Saudi Pharm J 2017; 25(3): 299-305.
[14]
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-45.
[15]
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992; 49(9): 2229-32.
[16]
Aljadhey H, Mahmoud MA, Ahmed Y, et al. Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: The (ADESA) prospective cohort study. BMJ Open 2016; 6(7): 1-8.
[17]
Schurig AM, Böhme M, Just KS, et al. Adverse Drug Reactions (ADR) and emergencies: The prevalence of suspected adr in four emergency departments in Germany. Dtsch Arztebl Int 2018; 115(15): 251.
[18]
Al-Arifi M, Abu-Hashem H, Al-Meziny M, Said R, Aljadhey HJSPJ. Emergency department visits and admissions due to drug related problems at Riyadh military hospital (RMH) Saudi Arabia. Saudi Pharm J 2014; 22(1): 17-25.
[19]
Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR. Pirmohamed MJPo. Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. PLoS One 2009; 4(2): e4439.
[20]
Franceschi M, Scarcelli C, Niro V, et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit. Drug Saf 2008; 31(6): 545-56.
[21]
Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168(17): 1890-6.
[22]
Pedrós C, Quintana B, Rebolledo M, Porta N, Vallano A. Arnau JMJEJoCP. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. Eur J Clin Pharmacol 2014; 70(3): 361-7.
[23]
Gallelli L, Siniscalchi A, Palleria C, et al. Adverse drug reactions related to drug administration in hospitalized patients. Curr Drug Saf 2017; 12(3): 171-7.
[24]
Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45(3): 301-8.
[25]
Hajjar ER, Hanlon JT, Artz MB, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 2003; 1(2): 82-9.
[26]
Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50(12): 1962-8.
[27]
Ahern F, Sahm LJ, Lynch D, McCarthy S. Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: A cross-sectional study. Emerg Med J 2014; 31(1): 24-9.
[28]
van der Hooft CS, Dieleman JP, Siemes C, et al. Adverse drug reaction-related hospitalisations: A population-based cohort study. Pharmacoepidemiol Drug Saf 2008; 17(4): 365-71.
[29]
Pratico AD, Longo L, Mansueto S, et al. Off-Label use of drugs and adverse drug reactions in pediatric units: A Prospective, multicenter study. Curr Drug Saf 2018; 13(3): 200-7.
